BioCentury
ARTICLE | Company News

GenOdyssee SA other research news

September 23, 2002 7:00 AM UTC

GenOdyssee said 9 of its IFN alpha variants showed up to 100 times greater efficacy compared to currently commercialized IFN alpha molecules in cells in culture and in mouse models of viral infection ...